Literature DB >> 25920524

Predictive factors of early moderate/severe ovarian hyperstimulation syndrome in non-polycystic ovarian syndrome patients: a statistical model.

Mahnaz Ashrafi1,2, Akram Bahmanabadi1, Mohammad Reza Akhond3, Arezoo Arabipoor4.   

Abstract

PURPOSE: To evaluate demographic, medical history and clinical cycle characteristics of infertile non-polycystic ovary syndrome (NPCOS) women with the purpose of investigating their associations with the prevalence of moderate-to-severe OHSS.
METHODS: In this retrospective study, among 7073 in vitro fertilization and/or intracytoplasmic sperm injection (IVF/ICSI) cycles, 86 cases of NPCO patients who developed moderate-to-severe OHSS while being treated with IVF/ICSI cycles were analyzed during the period of January 2008 to December 2010 at Royan Institute. To review the OHSS risk factors, 172 NPCOS patients without developing OHSS, treated at the same period of time, were selected randomly by computer as control group. We used multiple logistic regression in a backward manner to build a prediction model.
RESULTS: The regression analysis revealed that the variables, including age [odds ratio (OR) 0.9, confidence interval (CI) 0.81-0.99], antral follicles count (OR 4.3, CI 2.7-6.9), infertility cause (tubal factor, OR 11.5, CI 1.1-51.3), hypothyroidism (OR 3.8, CI 1.5-9.4) and positive history of ovarian surgery (OR 0.2, CI 0.05-0.9) were the most important predictors of OHSS. The regression model had an area under curve of 0.94, presenting an allowable discriminative performance that was equal with two strong predictive variables, including the number of follicles and serum estradiol level on human chorionic gonadotropin day. CONCLUSION(S): The predictive regression model based on primary characteristics of NPCOS patients had equal specificity in comparison with two mentioned strong predictive variables. Therefore, it may be beneficial to apply this model before the beginning of ovarian stimulation protocol.

Entities:  

Keywords:  Non-polycystic ovarian syndrome; OHSS; Risk factors; Statistical model

Mesh:

Substances:

Year:  2015        PMID: 25920524     DOI: 10.1007/s00404-015-3723-0

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  8 in total

1.  Predictive Factors for Recovery Time in Conceived Women Suffering From Moderate to Severe Ovarian Hyperstimulation Syndrome.

Authors:  Kai Huang; Ying Shi; Gezi Chen; Hao Shi; Jun Zhai
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-15       Impact factor: 6.055

2.  Sequential E2 levels not ovarian maximal diameter estimates were correlated with outcome of cetrotide therapy for management of women at high-risk of ovarian hyperstimulation syndrome: a randomized controlled study.

Authors:  Khalid M Salama; Hesham M Abo Ragab; Mohammed F El Sherbiny; Ali A Morsi; Ibrahim I Souidan
Journal:  BMC Womens Health       Date:  2017-11-13       Impact factor: 2.809

3.  A proteomic analysis identifies candidate early biomarkers to predict ovarian hyperstimulation syndrome in polycystic ovarian syndrome patients.

Authors:  Lan Wu; Yazhou Sun; Jun Wan; Ting Luan; Qing Cheng; Yong Tan
Journal:  Mol Med Rep       Date:  2017-05-18       Impact factor: 2.952

4.  Prognostic role of follicular fluid tumor necrosis factor alpha in the risk of early ovarian hyperstimulation syndrome.

Authors:  Miaad Jabbar Alhilali; Abbas Parham; Armin Attaranzadeh; Malihe Amirian; Mohammad Azizzadeh
Journal:  BMC Pregnancy Childbirth       Date:  2020-11-12       Impact factor: 3.007

5.  Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI.

Authors:  Bo Sun; Yujia Ma; Lu Li; Linli Hu; Fang Wang; Yile Zhang; Shanjun Dai; Yingpu Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-19       Impact factor: 5.555

6.  Nomogram Model to Predict the Probability of Ovarian Hyperstimulation Syndrome in the Treatment of Patients With Polycystic Ovary Syndrome.

Authors:  Fei Li; Ying Chen; Aiqin Niu; Yajing He; Ying Yan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-06       Impact factor: 5.555

7.  A Personalized Management Approach of OHSS: Development of a Multiphase Prediction Model and Smartphone-Based App.

Authors:  Mingzhu Cao; Zhi Liu; Yanshan Lin; Yiqun Luo; Sichen Li; Qing Huang; Haiying Liu; Jianqiao Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-06       Impact factor: 6.055

Review 8.  Safety of Follitropin Alfa/Lutropin Alfa for Stimulation of Follicular Development.

Authors:  Nadezda Abramova; Julie Hubbard; Joan Schertz; Emilia Richter
Journal:  Drug Saf       Date:  2019-03       Impact factor: 5.606

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.